Efficacy and safety of tocilizumab in Korean patients with active rheumatoid arthritis

BACKGROUND/AIMS: To investigate the efficacy and safety of tocilizumab (TCZ) humanized anti-interleukin-6 receptor monoclonal antibody, in Korean patients with active rheumatoid arthritis (RA) refractory to conventional disease modifying anti-rheumatic drugs (DMARDs) including methotrexate (MTX) MET...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Korean J Intern Med
Главные авторы: Baek, Han Joo, Lim, Mie Jin, Park, Won, Park, Sung Hwan, Shim, Seung-Cheol, Yoo, Dae-Hyun, Kim, Hyun Ah, Lee, Soo Kon, Lee, Yun Jong, Park, Young Eun, Cha, Hoon-Suk, Song, Yeong-Wook
Формат: Artigo
Язык:Inglês
Опубликовано: The Korean Association of Internal Medicine 2019
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6610180/
https://ncbi.nlm.nih.gov/pubmed/29334721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2017.159
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы